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Background: Traditional outcome measures in peripheral arterial disease (PAD) provide insufficient information
regarding patient benefit. It has therefore been suggested to add patient-reported outcome measures. The main
aim of this study was to validate the Swedish Vascular Quality of Life questionnaire (VascuQoL) version, a patient-
reported PAD-specific health-related quality of life (HRQoL) instrument.
Methods: Two-hundred PAD patients were consecutively recruited from two university hospitals. Out of the 200
subjects, 129 had intermittent claudication and 71 had critical limb ischemia. Mean age was 70 ± 9 y and 57% of the
participants were male. All patients completed SF-36 and VascuQoL at the vascular outpatient clinic, when
evaluated for invasive treatment. Risk factors and physiological parameters were registered. Construct validity was
tested by correlation analysis versus SF-36 and was also assessed with multitrait/multi-item scaling analysis (MTMI).
Sensitivity analysis regarding disease severity identification was performed. Reliability was assessed with Cronbach's
alpha and responsiveness by standardized response mean (SRM) calculations.
Results: Significant correlations were demonstrated between relevant subscales of VascuQoL and SF-36. MTMI
showed acceptable construct validity, but some scaling-errors. VascuQoL significantly (p< 0.001) discriminated
claudicants from critical limb ischemia patients. Cronbach's alpha was 0.94 and SRM 1.02 (sum score).
Conclusions: The Swedish version of VascuQoL is valid and quantifies central aspects of HRQoL in PAD patients.
Sensitivity analysis showed high ability to differentiate between disease severity and SRM illustrated excellent
responsiveness. The relative abundance of items however makes use in the everyday clinical setting somewhat difficult.
Keywords: Patient-reported outcome measures, Health-related quality of life, Peripheral arterial disease, Intermittent
claudication, Psychometric validationBackground
Invasive treatment of peripheral arterial disease (PAD)
improves limb-salvage in critical limb ischemia [1] and
potentially improves functional status in intermittent
claudication (pain in the legs during walking exercise,
due to reduced blood flow caused by atherosclerosis).
Traditionally used clinical outcome measures for evaluat-
ing the impact of disease as well as the effects of invasive
procedures in PAD include amputation-free survival,* Correspondence: joakim.nordanstig@vgregion.se
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reproduction in any medium, provided the origwalking capacity (e.g. treadmill testing), patency of revascu-
larized segments, and physiological measurements such as
the ankle-brachial index (ABI). With regard to patient bene-
fit, these objective measures may have several limitations.
Firstly, they do not provide sufficient information about
the actual daily functional capacity of the PAD patient.
Secondly, the degree of pain discomfort as experienced by
the patient is not covered by traditional measures. And
thirdly, they do not assess the impact of disease with respect
to social and emotional consequences of living with PAD.
Therefore, it has been suggested that traditional mea-
sures should be supplemented with patient-reported out-
come measures (PROMs) such as health-related quality
of life (HRQoL) instruments [2]. Such measures cantral Ltd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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making and assessment of results of different treatment
strategies, both in clinical practice and research.
HRQoL may be analyzed using generic or disease-
specific instruments. One well-known example of a gen-
eric instrument is the Medical Outcomes Study Short
Form 36 (SF-36), which is the most widely used general
health status measure. It is designed to provide assess-
ments regarding generic health concepts, making it ap-
plicable for use in wider populations, irrespective of age,
disease and treatment. Due to their general nature, gen-
eric instruments make comparisons possible between
different populations and patients groups. On the other
hand, generic instruments may be too insensitive to re-
veal smaller, but clinically important changes, because
they do not focus on the specific problems experienced
by PAD patients [3]. Moreover, these patients often are
affected not only by leg ischemia but often also by several
associated comorbidities that may negatively influence
HRQoL after a successful vascular procedure. Therefore,
the usage of disease-specific measures may be more
appropriate as a pre- versus post intervention measure [4].
For PAD, such instruments are generally scarce and at
present, no modern, formally validated disease-specific
instrument is available for use in Sweden.
Vascular Quality of Life questionnaire (VascuQoL), a
PAD-specific HRQoL instrument was developed at the Vas-
cular Surgical Unit of King’s College Hospital in London
[5]. The instrument has been translated to several lan-
guages [6], has been validated in the UK [7], and was for in-
stance used in the BASIL trial [8]. Due to potential cultural
and linguistic differences, most HRQoL experts opine that
any HRQoL instrument should be formally validated before
put to clinical use in a new country [9]. The main purpose
of this study was therefore to evaluate the validity, reliabil-
ity and responsiveness of the Swedish version of VascuQoL.
Methods
Study population
Two hundred subjects with established diagnosis of PAD
were consecutively recruited from vascular centers at
two university hospitals in Sweden. Out of the 200 sub-
jects, 129 had intermittent claudication and 71 had crit-
ical limb ischemia. All patients independently completed
the Swedish VascuQoL questionnaire and also the SF-36
instrument at the vascular outpatient clinic, when evalu-
ated for invasive treatment. At one of the vascular centers,
127 of the participating patients also completed both ques-
tionnaires six months after a vascular intervention.
Questionnaires
VascuQoL
VascuQoL aims at assessing quality of life over the entire
spectrum of PAD, i.e. both in intermittent claudicationand in critical limb ischemia. It consists of 25 items, sub-
divided into five domains: pain (four items), symptoms
(four items), activities (eight items), social (two items),
and emotional (seven items). Each question has a seven-
point response scale. The responses are averaged to give
an overall and a domain score ranging from one (worst
HRQoL) to seven (best HRQoL).
VascuQoL was translated to Swedish and linguistically
validated by the MAPI institute in France, specialized in
linguistic validations of patient-reported outcomes instru-
ments worldwide [6]. In close collaboration with the
original developers of health outcomes instruments, the
MAPI Institute has translated and linguistically validated
more than 500 instruments into over 151 languages in a
wide range of therapeutic areas.
SF-36
SF-36 is a well-established generic HRQoL questionnaire,
validated among patients with PAD in Sweden [10]. It
includes 36 items covering different aspects of HRQoL
in eight different domains (PF = physical functioning;
RP= role physical; BP = bodily pain; MH=mental health;
RE = role emotional; SF = social functioning; VT= vitality
and GH= general health). The response rates are ranging
from yes or no, to a three-to-six response scale. Results
are also presented in two summary measures, physical
health summary (pcs) and mental health summary (mcs).
Possible score ranges between 0–100 where 100 repre-
sent best possible HRQoL.
Additional measurements
Ankle-brachial index (ABI), blood pressure at the ankle
level divided by the blood pressure in the right forearm)
was measured using a non-directional pen doppler and a
standard blood pressure cuff. The highest value at each
ankle level was recorded. Information regarding pro-
spectively defined cardiovascular risk factors was col-
lected from the medical records.
Psychometric and statistical methods
Content validity
Five Swedish PAD experts subjectively evaluated face val-
idity of VascuQoL independently, analyzing the different
items in the translated Swedish version, with respect to
relevance for peripheral arterial disease.
Construct validity
The latent construct of VascuQoL was tested by correl-
ation analysis versus the different SF-36 subscales, using
Pearson correlation coefficient. Multitrait/multi-item
scaling analysis (MTMI) was also used to test scaling
assumptions. This approach has been extensively used
for the validation of HRQoL measures [11]. Ceiling-and
Table 1 Demograhics and risk factors in patient
population, n=200
Demographics and risk factors
Age (mean+ SD) 70 + 9 y
Gender (male/female; %) 57/43
Regulary smoking (current or in the last five years), % 49
Previous TIA or stroke, % 10
Diabetes, % 29
Hyperlipidemia, % 11
Angina pectoris/previous myocardial infarction, % 43
Chronic pulmonary disease, % 13
Kidney disease (s-creatinine >150 mmol/l), % 10
Ankle-brachial -index (mean + SD) 0.70 + 0.18
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normality.
Reliability
For reliability analysis, Cronbach's alpha was calculated for
each subscale of VascuQoL. Cronbach's alpha is a measure
of internal reliability, or consistency, i.e. how closely related
a set of items is as a group. A Cronbach's alpha value of
> 0.7 is generally considered acceptable for group data,
while 0.9 is recommended for individual assessment [12].
Sensitivity and responsiveness
Sensitivity was evaluated by testing the ability of Vascu-
QoL to discriminate between subjects with intermittent
claudication and critical limb ischemia, using the non-
parametric Mann–Whitney U test. Standardized re-
sponse mean (SRM) was used for responsiveness testing
and was calculated for each domain of VascuQoL, SF-36
and ABI (SRM=mean difference in score after vascular
intervention as compared to baseline, divided by the
standard deviation of the difference). Cohen's criteria
[13] for interpreting effect sizes were applied (small =
0.2–0.5, moderate = 0.5–0.8, large> 0.8). Relative effi-
ciency (ReE) was also calculated for relevant subscales of
VascuQoL and corresponding SF-36 subscales using the
formula ReE = (t1/t2)2, where t1 is the t value of a Stu-
dents paired t test for the relevant VascuQoL subscale
and t2 the relevant corresponding SF-36 subscale.
Statistical analysis was performed using SPSS version
19.0 (SPSS Inc. Chicago, IL, USA). The MTMI analysis
was performed using MAP-R for Windows, version 1.0.
Ethical considerations
Ethical approval was obtained from the Regional Ethical
Review Boards at the University of Lund (No. 315/2008)
and Gothenburg (No. 501/2009).
Results
Study population and missing data
Mean age was 70 ± 9 years and 57% of the subjects were
male. About one-half (49%) of the subjects were previous
or current smokers, 29% had diabetes and 43% had an-
gina pectoris or a previous history of myocardial infarc-
tion (Table 1). Missing data was low (0–3%) over all for
the 25 VascuQoL items, indicating that all questions are
possible to interpret and answer for the responders. In
the final dataset, 183 out of the 200 patients (92%) had
complete HRQoL registrations and all patients had com-
putable scales (using the half-scale method).
Validity
Content validity
Regarding face validity, all five PAD experts agreed that
VascuQoL covers central aspects of PAD disease. Questionswere raised about the relevance of the seven-point response
option and a reduction of possible response options was
suggested.
Construct validity
Correlation analysis showed significant correlations be-
tween several SF-36 subscales and VascuQoL domain
scores. The strongest correlations were noted between
VascuQoL activity subscale and SF-36 physical subscale
(PF) (r = 0, 69; p< 0.01) and between VascuQoL emo-
tional subscale and SF-36 mental subscale (MH) (r = 0,
68, p< 0.01). Also, the VascuQoL pain subscale corre-
lated strongly with SF-36 bodily pain, as did VascuQoL
total score and SF-36 physical component summary, psc.
This pattern was similar but augmented six months after
vascular intervention and VascuQoL activity subscale cor-
related more strongly with PF (r = 0,86; p< 0.01). Stronger
correlations were at that time also noted between Vascu-
QoL pain subscale and BP (r= 0, 78; p< 0.01) and between
the VascuQoL total score and SF-36 physical health sum-
mary (psc), (r = 0,79; p< 0.01), Table 2.
MTMI analysis was conducted to test the scaling
assumptions of VascuQoL and the results are summarized
in Table 3. Item-scale correlations indicated satisfactory
convergent validity for the subscales pain, social and emo-
tional, (i e correlations exceeded the minimum desired
level, r = 0.4). The activity subscale performed generally
well although one of eight item-scale correlations (item 9,
“During the past two weeks, the distance I can walk has
improved....”) was too low. The symptom subscale showed
a relatively poor convergent validity.
Regarding discriminant validity, the subscales activity
and emotional performed well, mainly correlating higher
with their own scale than with the other subscales. The
subscales pain, social and symptom were shown to have
relatively poor discriminant validity (Table 3). VascuQoL
correlated poorly to the baseline ABI values (Table 2).
The change in ABI did not correlate to change in Vascu-
QoL sum or domain scores.
Table 2 Cross-sectional construct validity - correlations




Pain Activities Symptoms Emotional Social
PF 0.65** 0.52** 0.69** 0.54** 0.49** 0.61**
n = 198 n = 200 n = 199 n = 200 n = 199 n = 199
0.83** 0.74** 0.86** 0.72** 0.73** 0.73**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
RP 0.53** 0.47** 0.51** 0.48** 0.42** 0.48**
n = 195 n = 197 n = 196 n = 197 n = 196 n = 196
0.70** 0.62** 0.66** 0.62** 0.65** 0.69**
n = 126 n = 126 n = 126 n = 126 n = 126 n = 126
BP 0.67** 0.62** 0.62** 0.57** 0.58** 0.49**
n = 196 n = 198 n = 197 n = 197 n = 197 n = 197
0.73** 0.78** 0.67** 0.69** 0.66** 0.57**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
GH 0.49** 0.36** 0.43** 0.38** 0.50** 0.44**
n = 196 n = 198 n = 197 n = 198 n = 197 n = 197
0.50** 0.41** 0.47** 0.45** 0.54** 0.40**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
VT 0.61** 0.49** 0.51** 0.55** 0.56** 0.49**
n = 197 n = 199 n = 198 n = 199 n = 198 n = 198
0.65** 0.57** 0.59** 0.60** 0.67** 0.53**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
SF 0.34** 0.21** 0.19** 0.29** 0.41** 0.43**
n = 197 n = 199 n = 198 n = 199 n = 198 n = 198
0.65** 0.51** 0.60** 0.60* 0.66** 0.66**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
RE 0.47** 0.37** 0.38** 0.41** 0.46** 0.41**
n = 196 n = 198 n = 197 n = 198 n = 197 n = 197
0.69** 0.60** 0.63** 0.60** 0.69** 0.72**
n = 126 n = 126 n = 126 n = 126 n = 126 n = 126
MH 0.58** 0.40** 0.41** 0.49** 0.68** 0.49**
n = 197 n = 199 n = 198 n = 199 n = 198 n = 198
0.62** 0.52** 0.52** 0.54** 0.70** 0.58**
n = 127 n = 127 n = 127 n = 127 n = 127 n = 127
PCS 0.59 0.53** 0.64** 0.50** 0.40** 0.52**
n = 192 n = 194 n = 193 n = 194 n = 193 n = 193
0.79** 0.74** 0.80** 0.71** 0.68** 0.66**
n = 126 n = 126 n = 126 n = 126 n = 126 n = 126
MCS 0.49** 0.31** 0.28** 0.42** 0.60** 0.45**
n = 192 n = 194 n = 193 n = 194 n = 193 n = 193
0.57** 0.45** 0.46** 0.49** 0.65** 0.58**
n = 126 n = 126 n = 126 n = 126 n = 126 n = 126
ABI 0.27** 0.15 0.22** 0.29** 0.24** 0.26**
n = 143 n = 145 n = 144 n = 145 n = 144 n = 144
Table 2 Cross-sectional construct validity - correlations
(Pearson) between VascuQoL and SF-36 scale scores
(Continued)
0.09 0.17 0.10 0.12 0.01 0.11
n = 112 n = 112 n = 112 n = 112 n = 112 n = 112
Correlations at six-months follow-up in italics (n = 121).
** Correlations are significant at the 0.01 level, (two-tailed test).
PF=physical functioning; RP= role physical; BP=bodily pain; GH=general
health; VT= vitality; SF= social functioning; RE= role emotional; MH=mental
health; PCS=physical health summary; MCS=mental health summary and
ABI= ankle-brachial-index.
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For the VascuQoL total score, Cronbach's alpha was 0.94
and for the subscales alpha values were acceptable
(alpha ≥ 0.7), except for the symptom subscale that had a
somewhat weak alpha value (0.64), Table 4.
Floor- and ceiling effects
Proportions of subjects scoring at the lowest possible
scale level (floor effect) were marginal for all subscales
(≤2.5%). Ceiling effects (proportion of subjects scoring at
the highest possible scale level) were also negligible, al-
though 6.5% of the subjects scored at the maximum scale
level of the social subscale. Floor-and ceiling effects for
the different VascuQoL subscales with respect to disease
severity are given in Table 5.
Sensitivity and responsiveness
VascuQoL was shown to discriminate significantly be-
tween subjects with intermittent claudication and critical
limb ischemia (Table 5). Standardized response mean
(SRM) for total and domain scores of VascuQoL, calcu-
lated for the 123 patients that completed the HRQoL
instruments also six months after a vascular intervention,
are given in Figure 1. SRM for VascuQoL total score was
1,02, indicating a large effect. All but one (social scale) of
the VascuQoL subscales demonstrated a SRM value over
0.8, which, according to applied criteria [13], indicate ex-
cellent responsiveness. In comparison with SRM for the
different SF-36 scores and ABI, VascuQoL performed
better (Figure 1). Relative efficiency (ReE) of the Vascu-
QoL activity subscale vs. the SF-36 physical functioning
subscale was 2,2, for VascuQoL pain subscale vs. SF-36
bodily pain subscale ReE =1,5; for VascuQoL emotional
subscale vs. SF-36 role emotional subscale ReE = 15,3
and for VascuQoL social subscale vs. SF-36 social func-
tioning subscale ReE = 8,1.
Discussion
The main finding in this study is that VascuQoL, a PAD-
specific HRQoL assessment questionnaire, is valid, reli-
able and responsive, thereby adequately reflecting central
aspects of HRQoL among patients living with PAD in
Sweden. The instrument showed a high ability to
Table 3 Summary of results of multitrait/multi-item scaling tests of the Swedish VascuQoL questionaire
Multitrait/multi-item scaling tests
Item-scale convergent validity Item-scale discriminant validity Scaling fulfillment
Range of r Criterion 1 Range of r Criterion 2
Scale Item-scale
correlationsa








criteria 1 and 2e
Activity 0.25–0.71 88 0.04–0.70 7/8 7/8
Pain 0.51–0.66 100 0.38–0.66 2/4 2/4
Emotional 0.59–0.76 100 0.42–0.64 5/7 5/7
Social 0.55–0.55 100 0.48–0.70 0/2 0/2
Symptom 0.3–0.55 50 0.29–0.63 0/4 0/4
aPearson correlations between items and hypothesized scale (corrected for overlap).
bNumber of item-scale correlations that meet the minimum standard for convergent validity (r≥ 0.40)/total numbers of correlations.
cPearson correlations between items and competing scales.
dCorrelations higher between items and hypothesized scale in comparison with all other scales.
eItems in each scale that meet criteria for both item-scale convergent (Criterion1) and discriminant (Criterion 2) validity.
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tion and patients with critical limb ischemia, indicating a
high sensitivity to quantify HRQoL in this patient group.
It also seems to be a reliable instrument, as judged by
high values of Cronbach's alpha for the sum and most
subscale scores. Moreover, responsiveness seems to be
excellent as illustrated by our SRM calculations and the
instrument would therefore be ideal as an additional out-
come measure after vascular surgical intervention. Vas-
cuQoL has been validated in the UK before [7], but the
Swedish culture and treatment options may differ, why it
is important that the instrument is now also formally
validated from a Swedish culture and context [9].
In comparison with the analysis made by the original
VascuQoL developers [5], we found a similar pattern
with regard to construct validity and responsiveness. The
VascuQoL domains activity and pain correlated strongly
with PF and BP respectively. We noticed a somewhat
stronger correlation (r = 0.68) between VascuQoL emo-
tional and MH, possibly explained by our larger patient
sample. Regarding responsiveness, setting the limit for
acceptable results at a SRM >0.5 [13], all domain scores
of VascuQoL performed well, whereas only three (PF, RPTable 4 Crohnbach’s alpha values for the different









Activity 0.87 (n = 189) 0.86 (n = 126) 0.78 (n = 63) 0.94 (n = 124)
Pain 0.77 (n = 195) 0.74 (n = 126) 0.78 (n = 69) 0.89 (n = 127)
Emotional 0.88 (n = 192) 0.85 (n = 127) 0.89 (n = 65) 0.94 (n = 127)
Social 0.70 (n = 196) 0.67 (n = 127) 0.68 (n = 69) 0.84 (n = 127)
Symptom 0.64 (n = 194) 0.56 (n = 127) 0.61 (n = 60) 0.73 (n = 126)
Total 0.94 (n = 183) 0.93 (n = 123) 0.92 (n = 60) 0.97 (n = 123)and BP) out of eight domains of SF-36 were responsive.
Similar findings were also made in the Dutch version of
VascuQoL by de Vries et al [3]. Clinical indicators such
as ABI correlated poorly to HRQoL scores, as have been
demonstrated by other authors [5,7,14]. To summarize
these findings, our present data confirm that VascuQoL
is a valid instrument for measurements of outcomes after
vascular interventions.
Minimal important difference (MID) of a change in
HRQoL is ideally determined using patient-based and
clinical anchors [15]. Our data set did not allow for such
an approach as we did not use transition questions.
Moreover, we found that the ABI values correlated
poorly to HRQoL, making their use as clinical anchors
problematic [16]. However, as described by Norman et al
[17] the threshold of discrimination for changes in
HRQoL appears to be around half a standard deviation
(SD). Using this definition, minimal important difference
(MID) for VascuQoL total score in our sample would be
0,58. Applying this on our data set, 72% of our subjects
reached a MID after vascular intervention. Setting the
limit for MID at 0,2 SD would result in a MID for
VascuQoL total score of 0,23 and 76% of the subjects
reaching MID.
There are a few concerns about some parts of the scale
constructs, with possible implications for the validity of
the instrument. Multitrait-multi-item scaling tests indi-
cated scaling errors in all domains, although most were
of minor importance. Weak item-scale convergent and
discriminant validity were shown for the symptom scale.
However, since this scale contains items on symptoms
that can cause deterioration in HRQoL (so-called “causal
indicators”) the construct should be regarded as a clini-
metric scale [18]. Traditional psychometric scaling ana-
lysis is based on the assumption that all items are “effect
indicators” reflecting the same latent construct, thus
leading to high correlation structure and high internal

















Activity 3.50 ± 1.12 2.44 ± 0.88 p< 0.001 0 0 4.2 0
Pain 3.69 ± 1.18 2.61 ± 1,10 p< 0.001 0.8 0 8.5 0
Emotional 4.57 ± 1,29 3.35 ± 1,48 p< 0.001 0 0.8 2.8 1.4
Social 4.34 ± 1.60 3.17 ± 1,63 p< 0.001 0 7.1 5.6 5.6
Symptom 4.46 ± 1.09 2.97 ± 1,23 p< 0.001 0 0 5.6 0
Total 4.05 ± 1.03 2.87 ± 1.00 p< 0.001 0 0 1.4 0
Higher scores indicates better health status.
*Proportion of subjects scoring at the lowest possible scale level.
Proportion of subjects scoring at the highest possible scale level.
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ally more heterogeneous, leading to weaker correlation
structure and lower internal consistency. Evaluation of
clinimetric scales should be based on content validity
and clinical usefulness rather than internal consistency
[18]. The satisfactory responsiveness demonstrated in the
present and other studies [5,7] indicates that the symp-
tom scale is of clinical importance for measuring effects
of treatment.
Item-scale convergent validity was satisfactory for the
pain, emotional, social and activity domains, with one ex-
ception. One item (item 9) in the activity domain corre-
lated weakly, indicating that this item may be removedFigure 1 Standardized response mean (SRM) after vascular interventio
SF-36 subscales. ABI= ankle-brachial index; PF=physical functioning; RP=
SF= social functioning; RE= role emotional MH=mental health; PCS=physi
for interpreting effect size: 0,0–0,2 = trivial; 0,2–0,5 = small; 0,5–0,8 =moderatwithout loss of information. This may be explained by
the somewhat illogical construction of that item, i e one
cannot expect that the patients have improved their
walking capacity at baseline. Item-scale discriminant val-
idity was generally weaker, especially for the social and
pain domains. The social domain consists of only two
items which both correlated higher with other domains.
The social domain may perhaps be improved by adding
one or more additional items. Items in the pain domain
were somewhat unspecific with moderate correlations
with several scales.
One possible disadvantage, which was also commented
by the expert group in our study, is the seven-pointn; for ABI (ankle-brachial index) and the different VascuQoL and
role physical; BP=bodily pain; GH=general health; VT= vitality;
cal health summary and MCS=mental health summary. Cohen’s criteria
e; >0,8 = large.
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used in the SF-36 version 1 for measuring VT and MH
was changed in version 2 to a 5-point scale. Elimination
of one response choice simplified the form without loss
of information [19]. This suggests that further develop-
ment and tests of VascuQoL should include a reduction
of the seven-point response scale.
For the vascular surgery community, it is important to
integrate patient-reported outcome measures in daily
practice. Such measurements offer important additional
information about the vascular patient that could be
used for the evaluation of different invasive treatment
modalities and possibly also as an evaluation tool for
proper selection of patients to offer invasive treatment
[20,21]. Moreover, they are important additional out-
come variables in clinical research. Of special importance
is the evaluation of different treatment options with
seemingly similar short- and long-term objective out-
come (e.g. regarding amputation-free survival; mortality
etc.). In such cases it is obviously very important to offer
the patient the procedure that results in less HRQoL re-
duction, caused by the surgical procedure per se. This is
for instance the case sometimes when comparing endo-
vascular and open vascular procedures. HRQoL mea-
sures ideally could offer such important information in
daily practice. But at the same time, these instruments
ought to be easy to fill out and contain a limited amount
of items, to be really practical to use in the broader
everyday clinical setting.
Limitations of our validation strategy includes that we,
for resource reasons, did not perform test-retest reliabil-
ity assessment. Moreover, due to the somewhat limited
study sample, our dataset did not allow for formal factor
analysis that could demonstrate how well the hypothe-
sized factors explain the observed data.
Conclusions
In conclusion, our data shows that the Swedish VascuQoL
version is a valid HRQoL instrument in PAD, confirming
previously observed results regarding the original English
version [5]. Although there are a few improvements in the
scale construct to be made, the performance in our study
was generally acceptable-to-good. Drawbacks of Vascu-
QoL concern mainly the relatively abundance of questions
and the seven-point response scale, making broad use in
the everyday clinical setting somewhat difficult. A short
version of the instrument may be possible and more prac-
tical, and we will continue our work in that direction.
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